Cardiol Therapeutics Inc.
CRDL
$1.15
$0.00990.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.99M | -25.77M | -26.80M | -26.57M | -21.66M |
| Total Depreciation and Amortization | 110.00K | 136.80K | 165.10K | 179.60K | 188.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.78M | 8.25M | 9.02M | 7.60M | 4.01M |
| Change in Net Operating Assets | -872.90K | -786.60K | -703.80K | -280.50K | 1.54M |
| Cash from Operations | -17.97M | -18.17M | -18.32M | -19.07M | -15.92M |
| Capital Expenditure | -23.20K | -21.30K | -15.60K | -19.10K | -17.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.20K | -21.30K | -15.60K | -19.10K | -17.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -46.00K | -41.40K | -41.40K | -41.40K | -50.60K |
| Issuance of Common Stock | 21.39M | 21.44M | 21.53M | 177.50K | 177.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.65M | -2.65M | -2.65M | -- | -- |
| Cash from Financing | 13.35M | 13.40M | 13.46M | 100.10K | 93.20K |
| Foreign Exchange rate Adjustments | 405.20K | 920.10K | 1.36M | 861.20K | 399.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.23M | -3.87M | -3.51M | -18.13M | -15.45M |